Fig. 1
Number of reports of chemotherapy alone (pemetrexed and platinum) and combination therapy (pemetrexed and platinum plus pembrolizumab) from the second quarter of 2017 to the third quarter of 2024
Fig. 1 | BMC Cancer
Number of reports of chemotherapy alone (pemetrexed and platinum) and combination therapy (pemetrexed and platinum plus pembrolizumab) from the second quarter of 2017 to the third quarter of 2024